Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees

Stopped early · Phase 4

Conditions studied: Alcohol Dependence

In brief

The purpose of this study is to test how tolerable and effective acamprosate is when used to prevent alcohol relapse in criminal justice supervisees (those on probation, parole, or in drug court).

Key facts

Study ID

NCT00249379

Run by

Virginia Commonwealth University

People needed

26

Starts

2005-06-01

Expected to finish

2008-08-01

Last updated by the study team

2016-05-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of alcohol dependence in the year before entering criminal justice supervision
• Currently under criminal justice supervision (drug court, probation, or parole) in central Virginia

You may not qualify if…

• Pregnant or nursing a baby
• Known sensitivity to acamprosate
• Elevated serum creatinine level or other evidence of kidney problems
• Symptoms of severe depression or suicidal ideation
• Non-English speaking such that they cannot provide informed consent
• Cognitive impairment such that they cannot provide informed consent

Where it is running

• Virginia Commonwealth University Medical Center — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.